Parmax Pharma
PARMAXBSE

Parmax Pharma

₹59.322.82 (4.99%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
59.32
Today’s high
59.32
52 week low
22.60
52 week high
59.32
Open price
59.32
Previous close
56.50
Live volume
9,545
Lower circuit
56.36
Upper circuit
62.28

Fundamentals

Market Cap
₹22Cr
ROE
67.65%
P/E Ratio(TTM)
--
EPS(TTM)
-11.12
P/B Ratio
0.00
Dividend Yield
0.00%
Industry P/E
45.21
Book Value
-18.33
Debt to Equity
-1.87
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹3.34
-23.04%
Profit (Cr)
-₹0.58
+20.55%
-4-1.502.55
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-29%
3Y CAGR+16%
Profit growthValue
1Y (TTM)+157%

About

Parmax Pharma Limited manufactures pharmaceutical formulations, including tablets, capsules, and ointments.;
CEO/MD
Dr. Umang A. Gosalia
Founded in
1994
BSE symbol
540359

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
69.20%
Promoters
30.80%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹4,509.20
-63.70 (1.39%)
L
    H
    20,631.7728.564.91
    ₹8,249.50
    +21.00 (0.26%)
    L
      H
      20,609.75109.923.61
      ₹1,404.60
      +39.00 (2.86%)
      L
        H
        19,439.6030.024.98
        ₹766.45
        +3.30 (0.43%)
        L
          H
          18,983.7231.913.73
          2026
          30
          May
          Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks